RARE · Ultragenyx Pharmaceutical Inc.
Market Cap
$1.51B
Shares
98.59M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1515673
CUSIP
90400D108
13F (30d)
220 filings
219 filers
Visit website
Investor relations